NCT06860438 Observational Study About the Use of Perfusion Index to Use Vasopressor in Sepsis
| NCT ID | NCT06860438 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2025-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2024-08-01 with a primary completion date of 2025-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this thesis we will use the current state of knowledge that PI can provide a reliable information about the state of peripheral microcirculation during the state of sepsis and septic shock in ICU patients and that can interfere with the timing of starting vasopressor treatment in sepsis and septic shock
Eligibility Criteria
Inclusion Criteria: \- All ICU patients with clinically suspected sepsis and septic shock ( signs include fever hypotension oliguria and confusion combined with culture results showing infection .Septic shock is a subset of sepsis involves persistent hypotension (mean arterial pressure ≥ 65 mm Hg, and a serum lactate level \> 18 mg/dL \[2 mmol/L)not responding to fluid resuscitation ) . Exclusion Criteria: * Pregnant females * Patients on vasopressor or positive inotropic drugs * Patients with hypothermia (defined as central temperature \<35°C). * Patient with impairment of upper extremity circulation,(such as those who underwent radial artery harvesting for coronary artery bypass grafting or had suspected occlusion of the radial artery prior to surgery,) * Patients had undergone an operation that involved the large arteries of the aortic arch. * Patients with atherosclerosis .
Contact & Investigator
Nancy shaker ass,lecurer
PRINCIPAL INVESTIGATOR
faculty of medicine, Ain Shams University
Frequently Asked Questions
Who can join the NCT06860438 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06860438 currently recruiting?
Yes, NCT06860438 is actively recruiting participants. Contact the research team at nancy.shaker@med.asu.edu.eg for enrollment information.
Where is the NCT06860438 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06860438 clinical trial?
NCT06860438 is sponsored by Ain Shams University. The principal investigator is Nancy shaker ass,lecurer at faculty of medicine, Ain Shams University. The trial plans to enroll 40 participants.